These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6323334)

  • 1. Medical treatment of Zollinger-Ellison syndrome with ranitidine.
    Vezzadini P; Bonora G; Tomassetti P; Pazzaglia M; Labò G
    Int J Tissue React; 1983; 5(4):339-43. PubMed ID: 6323334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
    Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [24-hour intragastric acid profile in a ZES patient with H2 blockers].
    Dammann HG; Müller P; Simon B; Kommerell B
    Z Gastroenterol; 1984 Jun; 22(6):318-20. PubMed ID: 6147052
    [No Abstract]   [Full Text] [Related]  

  • 4. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome.
    Raufman JP; Collins SM; Pandol SJ; Korman LY; Collen MJ; Cornelius MJ; Feld MK; McCarthy DM; Gardner JD; Jensen RT
    Gastroenterology; 1983 Jan; 84(1):108-13. PubMed ID: 6128284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
    Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
    Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of gastric acid hypersecretion in the Zollinger-Ellison syndrome with a thioamide derivative (40749 RP). Comparison with ranitidine].
    Bonfils S; Vallot T; Garcia del Risco F; Mignon M
    Gastroenterol Clin Biol; 1986; 10(6-7):486-91. PubMed ID: 3758592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Maton PN; Gardner JD; Jensen RT
    Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic interaction between an H2-receptor antagonist and enprostil on 24-hour intragastric pH, serum gastrin concentration, and tissue immunoperoxidase staining for gastrin, somatostatin, and serotonin in a patient with metastatic gastrinoma.
    Sherbaniuk R; Jewell LD; Yacoub W; Pinchbeck B; Salkie ML; Walker K; Mahachai V; Kirdeikis P; Zuk L; Brunet MK
    Clin Ther; 1986; 8(6):667-88. PubMed ID: 2878726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome.
    Bonfils S; Mignon M; Vallot ; Mayeur S
    Scand J Gastroenterol Suppl; 1981 Jun; 69():119-23. PubMed ID: 6119775
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring.
    Vallot T; Mignon M; Mazure R; Bonfils S
    Dig Dis Sci; 1983 Jul; 28(7):577-84. PubMed ID: 6305607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study.
    Maton PN; Frucht H; Vinayek R; Wank SA; Gardner JD; Jensen RT
    Gastroenterology; 1988 Feb; 94(2):294-9. PubMed ID: 3335308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of Zollinger-Ellison syndrome].
    Steegmüller KW
    Zentralbl Chir; 1989; 114(9):603-5. PubMed ID: 2741586
    [No Abstract]   [Full Text] [Related]  

  • 13. An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.
    Morocutti A; Merrouche M; Bjaaland T; Humphries T; Mignon M
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1439-44. PubMed ID: 17081164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.
    Metz DC; Strader DB; Orbuch M; Koviack PD; Feigenbaum KM; Jensen RT
    Aliment Pharmacol Ther; 1993 Dec; 7(6):597-610. PubMed ID: 8161665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous recording of gastric pH to assess the efficacy of antisecretory drugs in Zollinger-Ellison syndrome].
    Galmiche JP; Mignon M; Ducrotte P; Mayeur S; Arsene D; Vallot T
    Nouv Presse Med; 1981 Feb; 10(6):432-3. PubMed ID: 6111787
    [No Abstract]   [Full Text] [Related]  

  • 16. Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Vinayek R; Hahne WF; Euler AR; Norton JA; Jensen RT
    Dig Dis Sci; 1993 Oct; 38(10):1857-65. PubMed ID: 8104773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cimetidine, ranitidine and somatostatin in the medical treatment of acute and chronic Zollinger-Ellison syndrome].
    Gordillo J; Varas MJ
    Rev Esp Enferm Apar Dig; 1987 Dec; 72(6):749-50. PubMed ID: 2894045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Zollinger-Ellison syndrome: long-term treatment with ranitidine].
    Mony M; Lavoie S; Lemire S
    Union Med Can; 1986 Mar; 115(3):149-50. PubMed ID: 3705262
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
    Mignon M; Hochlaf S; Forestier S; Ruszniewski P; Vatier J; Joubert-Collin M
    Gastroenterol Clin Biol; 1994; 18(1):13-6. PubMed ID: 8187984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastric secretory, ultrastructural and pH changes during prolonged treatment with omeprazole in a severe form of Zollinger-Ellison syndrome].
    Mignon M; Alcabes G; Lehy T; Nguyen Phuoc BK; Vatier J; Bonfils S
    Gastroenterol Clin Biol; 1984 Dec; 8(12):947-54. PubMed ID: 6519403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.